You are here

Bayer

How Bayer cracked the retail media code

Medical Marketing and Media

Thu, 01/16/25 - 09:40 pm

DTC advertising

JPM25: Bayer gears up for 'must-win battles' as Xarelto's decline is in full swing, pharma chief says

Fierce Pharma

Thu, 01/16/25 - 11:16 am

Bayer will focus on debt reduction rather than acquisitions in the coming years

Marketscreener

Tue, 01/14/25 - 11:06 am

JPM25: Bayer moves allogeneic cell therapy into phase 3 Parkinson's trial

Fierce Biotech

Mon, 01/13/25 - 11:13 am

Parkinson's Disease

clinical trials

Bayer makes hot flash splash, hitting phase 3 breast cancer goal to steal march on Astellas

Fierce Biotech

Thu, 01/9/25 - 11:11 am

clinical trials

Regeneron, Bayer Build Retinal Vein Occlusion Case for Eylea as Biosimilar Pressure Mounts

BioSpace

Wed, 12/18/24 - 11:12 am

retinal vein occlusion

Bayer expands indications for Nubeqa with new drug application

Clinical Trials Arena

Thu, 11/21/24 - 11:39 am

prostate cancer

Bayer lands regional rights to aficamten in Japan deal with Cytokinetics

First Word Pharma

Tue, 11/19/24 - 11:20 am

hypertrophic cardiomyopathy

Bayer share price falls as pharma giant’s results fail to cheer investors

MSN

Tue, 11/12/24 - 11:01 am

Bayer, Dewpoint Therapeutics Sign Deal for Heart-Disease Treatment

Morningstar

Thu, 10/24/24 - 11:01 am

Dewpoint Therapeutics

heart-muscle disease

Bayer partners medtech firm Impli on fertility R&D

Pharmaphorum

Thu, 10/24/24 - 09:48 am

Big Pharma's layoff wave in New Jersey rolls on with hundreds of J&J cuts, 57 at Bayer

Fierce Pharma

Tue, 10/1/24 - 10:19 pm

Navigating the AI 'hype cycle': Bayer, Daiichi Sankyo and argenx leaders on implementing AI in biopharma marketing

Fierce Pharma

Thu, 09/19/24 - 11:06 am

artificial intelligence

ESMO: Bayer hopes to expand Nubeqa's prostate cancer reach with chemo-free regimen

Fierce Pharma

Mon, 09/16/24 - 09:58 am

prostate cancer

Roivant unveils new ‘vant’ to take forward Bayer’s inhaled hypertension med

Fierce Biotech

Tue, 09/10/24 - 08:56 am

Roivant Sciences

pulmonary hypertension

What 3 layoff stories reveal about pharma’s troubles

Pharma Voice

Fri, 09/6/24 - 10:48 am

Tome Biosciences

Bayer’s kidney disease drug Kerendia reduces cardiovascular risk by 16%

BioSpace

Tue, 09/3/24 - 11:31 am

cardiovascular disease

clinical trials

New data reveal how Bayer's asundexian failed to prevent strokes, imperiling $5.5B blockbuster hopes

Fierce Biotech

Mon, 09/2/24 - 12:18 pm

clinical trials

atrial fibrillation

Bayer partners with NextRNA on lncRNA-targeted small molecules for cancer

First Word Pharma

Wed, 08/28/24 - 11:38 am

Bayer layoffs hit Switzerland with 150 cuts at Basel consumer health hub

Fierce Pharma

Sun, 08/25/24 - 11:09 pm

consumer health

Pages